Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Cardiol Therapeutics Inc (CRDL)

46 + Investors. Track Smart Money conviction in CRDL. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +4
Streak
1Q ▲
Buyers last Q
56%

Smart Money Signals — CRDL

Based on 46 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added CRDL than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (98% of max)

98% of all-time peak
46 hedge funds hold CRDL right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +21% more funds vs a year ago

fund count last 6Q
+8 new funds entered over the past year (+21% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 56% buying

22 buying17 selling
Last quarter: 22 funds bought or added vs 17 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~13 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 9 → 15 → 9 → 13. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

41% of holders stayed for 2+ years

■ 41% conviction (2yr+) ■ 22% medium ■ 37% new
19 out of 46 hedge funds have held CRDL for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +326% but shares only +201% — price-driven

Value
+326%
Shares
+201%
Last quarter: the total dollar value of institutional holdings rose +326%, but actual share count only changed +201%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
➡️

Steady discovery — ~13 new funds/quarter

5 → 9 → 15 → 9 → 13 new funds/Q
New funds entering each quarter: 9 → 15 → 9 → 13. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Veteran-anchored — 52% veterans vs 38% newcomers

■ 52% veterans ■ 10% 1-2yr ■ 38% new
Entry-cohort mix of 48 holders: 25 (52%) are 2+ year veterans, 5 entered 1–2 years ago, and 18 (38%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
📋

Smaller funds dominant — 6% AUM from top-100

6% from top-100 AUM funds
11 of 46 holders rank in the top 100 by AUM, but together hold only 6% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
3.9
out of 10
Low Exit Risk
Exit risk score 3.9/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — CRDL

In 2026 Q1, 22 hedge funds were net buyers of CRDL (13 opened a new position, 9 added to an existing one), while 17 reduced or exited (8 trimmed, 9 sold completely) — a 56% buyer ratio, indicating a slight buying edge. Net fund flow last quarter: +4 funds (more new holders than closures). Total institutional holders: 46.

Hedge Fund Ownership: CRDL

How many hedge funds hold CRDL — quarterly history vs. share price
Quarterly hedge fund ownership of CRDL vs. share price

Market Analysis: CRDL

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: CRDL

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Cardiol Therapeutics Inc (CRDL) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much CRDL has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 77d ago
CRDL
-24.1%
XLV
+4.2%

CRDL outperformed XLV by -28.3% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 32d ago
CRDL
-22.3%
XLV
+5.3%

Since the filing became public, CRDL outperformed XLV by -27.6% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

4 top-rated funds 2 high-conviction
Consensus
3.0
/ 10
breadth
×
Elite
2.2
/ 10
conviction
Hedge Fund Positioning: CRDL
46 + Investors

Track Smart Money conviction in CRDL. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 46 42 9.52%
13F Shares 28M 9M 201.1%
Total Value $38M $9M 326.14%
New Positions 13 9 +4
Increased Positions 9 11 -2
Closed Positions 9 14 -5
Reduced Positions 7 13 -6
Total Calls 2 3 -33.33%
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: CRDL

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

46 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in CRDL. Verified SEC 13F-HR filings.

QUARTER:
Top 25 CRDL holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Tejara Capital Ltd 2.28% 5,130,122 $6.9M
2 MMCAP International Inc. SPC 1.79% 15,352,317 $20.7M
3 Ikarian Capital, LLC 0.30% 2,725,000 $3.7M
4 Knoll Capital Management, LLC 0.07% 100,000 $135K
5 Boyer Financial Services, Inc. 0.03% 23,100 $31K
6 Security National Bank of Sioux City Iowa /Ia/ 0.03% 33,000 $45K
7 Integrity Alliance, LLC. 0.02% 465,025 $630K
8 Scientech Research LLC 0.02% 15,178 $20K
9 Boothbay Fund Management, LLC 0.01% 794,881 $1.1M
10 Boomfish Wealth Group, LLC 0.01% 14,423 $19K
11 Piscataqua Savings Bank 0.01% 5,000 $10K
12 Eaton Financial Holdings Company, LLC 0.01% 14,000 $19K
13 Marble Harbor Investment Counsel, LLC 0.01% 39,900 $54K
14 Mgo One Seven LLC 0.00% 100,000 $135K
15 Kovack Advisors, Inc. 0.00% 30,000 $42K
16 Impact Partnership Wealth, LLC 0.00% 10,850 $15K
17 Summit Financial, LLC 0.00% 104,059 $140K
18 Moneco Advisors, LLC 0.00% 15,000 $20K
19 Baader Bank Aktiengesellschaft 0.00% 15,932 $10K
20 Quadrature Capital Ltd 0.00% 47,887 $65K
21 Two Sigma Investments, LP 0.00% 534,211 $721K
22 Renaissance Technologies LLC 0.00% 229,806 $310K
23 Advisory Services Network, LLC 0.00% 10,000 $14K
24 Citadel Advisors LLC 0.00% 819,904 $1.1M
25 Wealthspire Advisors, LLC 0.00% 15,151 $20K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Cardiol Therapeutics Inc (CRDL)

What does the Smart Money Trend signal show for CRDL?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added CRDL than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for CRDL?

Slight buying edge — 56% buying: Last quarter: 22 funds bought or added vs 17 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for CRDL holders?

Smaller funds dominant — 6% AUM from top-100: 11 of 46 holders rank in the top 100 by AUM, but together hold only 6% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held CRDL?

41% of holders stayed for 2+ years: 19 out of 46 hedge funds have held CRDL for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Cardiol Therapeutics Inc (CRDL) following the 2026 Q1 hedge fund 13F filings?

As of today, CRDL has moved -22.3% since the 2026 Q1 13F filing date (May 15, 2026), compared to +5.3% for the XLV sector ETF — an outperformance of -27.6%. Since the quarter end (March 31, 2026), CRDL has gained -24.1% vs +4.2% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →